ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 171 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2019. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $220,870 | -12.7% | 4,788 | -21.8% | 0.01% | +55.6% |
Q3 2022 | $253,000 | +9.1% | 6,119 | +121.8% | 0.01% | +50.0% |
Q4 2021 | $232,000 | -37.1% | 2,759 | -28.7% | 0.01% | -45.5% |
Q2 2021 | $369,000 | +63.3% | 3,869 | +94.9% | 0.01% | +83.3% |
Q1 2021 | $226,000 | +247.7% | 1,985 | +150.0% | 0.01% | +100.0% |
Q3 2020 | $65,000 | -90.0% | 794 | -90.5% | 0.00% | -91.7% |
Q2 2020 | $651,000 | +425.0% | 8,322 | +197.2% | 0.04% | +350.0% |
Q1 2020 | $124,000 | +1277.8% | 2,800 | +2070.5% | 0.01% | +700.0% |
Q1 2019 | $9,000 | -98.2% | 129 | -98.4% | 0.00% | -97.9% |
Q2 2017 | $497,000 | +163.0% | 8,000 | +167.3% | 0.05% | +80.8% |
Q1 2016 | $189,000 | – | 2,993 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |